Norman Sharpless - 22 Jul 2022 Form 3 Insider Report for G1 Therapeutics, Inc.

Role
Director
Signature
/s/ James Stillman Hanson, attorney-in-fact
Issuer symbol
N/A
Transactions as of
22 Jul 2022
Net transactions value
$0
Form type
3
Filing time
02 Aug 2022, 18:44:31 UTC
Next filing
05 Aug 2022
SEC
View on sec.gov

No securities are beneficially owned.